Viewing Study NCT06041620


Ignite Creation Date: 2025-12-25 @ 4:11 AM
Ignite Modification Date: 2026-01-29 @ 9:35 AM
Study NCT ID: NCT06041620
Status: RECRUITING
Last Update Posted: 2023-10-17
First Post: 2023-09-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy Evaluation of Autologous CRISPR-Cas12b Edited Hematopoietic Stem Cells
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Thalassemia, Beta View
None Thalassemia Major View
Keywords: